alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Term ID

CHEBI:72009

Synonyms

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
alpha-Neu5Ac-(2->6)-beta-D-GlcNAc-(1->4)-D-GlcNAc
N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-D-glucosamine
Neu5Aca2-6GlcNAcb1-4GlcNAc
Neu5Acalpha2-6GlcNAcbeta1-4GlcNAc
O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->6)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-D-glucopyranose

Definition

An amino trisaccharide comprising α-sialyl, N-acetyl-β-D-glucosaminyl and N-acetyl-D-glucosamine linked in a (2→6) and (1→4) sequence.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Phenotype where environments contain alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Phenotype modified by environments containing alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Phenotype affecting alpha-Neup5Ac-(2->6)-beta-D-GlcpNAc-(1->4)-D-GlcpNAc

Human Disease Model